- Home
- GNFT vs CFBK Comparison
GNFT vs CFBK Comparison
Compare GNFT & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- CFBK
- Stock Information
- Founded
- GNFT 1999
- CFBK 1892
- Country
- GNFT France
- CFBK United States
- Employees
- GNFT N/A
- CFBK N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- CFBK Major Banks
- Sector
- GNFT Health Care
- CFBK Finance
- Exchange
- GNFT Nasdaq
- CFBK Nasdaq
- Market Cap
- GNFT 179.7M
- CFBK 145.9M
- IPO Year
- GNFT 2019
- CFBK 1998
- Fundamental
- Price
- GNFT $3.91
- CFBK $24.93
- Analyst Decision
- GNFT Strong Buy
- CFBK
- Analyst Count
- GNFT 1
- CFBK 0
- Target Price
- GNFT $13.00
- CFBK N/A
- AVG Volume (30 Days)
- GNFT 9.9K
- CFBK 24.8K
- Earning Date
- GNFT 09-19-2024
- CFBK 02-10-2025
- Dividend Yield
- GNFT N/A
- CFBK 1.16%
- EPS Growth
- GNFT N/A
- CFBK N/A
- EPS
- GNFT 0.47
- CFBK 2.04
- Revenue
- GNFT $86,225,222.00
- CFBK $44,396,000.00
- Revenue This Year
- GNFT $145.20
- CFBK N/A
- Revenue Next Year
- GNFT N/A
- CFBK N/A
- P/E Ratio
- GNFT $7.89
- CFBK $11.63
- Revenue Growth
- GNFT 175.45
- CFBK N/A
- 52 Week Low
- GNFT $3.35
- CFBK $16.92
- 52 Week High
- GNFT $6.42
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- GNFT 49.41
- CFBK 50.54
- Support Level
- GNFT $3.68
- CFBK $23.26
- Resistance Level
- GNFT $4.03
- CFBK $25.25
- Average True Range (ATR)
- GNFT 0.15
- CFBK 0.64
- MACD
- GNFT 0.05
- CFBK 0.24
- Stochastic Oscillator
- GNFT 57.35
- CFBK 73.30
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.